Equities
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in CNYIncome statement in CNYView more

Year on year Meituan grew revenues 25.82% from 219.95bn to 276.74bn while net income improved from a loss of 6.69bn to a gain of 13.86bn.
Gross margin36.50%
Net profit margin7.37%
Operating margin7.06%
Return on assets8.17%
Return on equity14.89%
Return on investment12.08%
More ▼

Cash flow in CNYView more

In 2023, Meituan increased its cash reserves by 65.39%, or 13.18bn. The company earned 40.52bn from its operations for a Cash Flow Margin of 14.64%. In addition the company used 24.66bn on investing activities and also paid 2.78bn in financing cash flows.
Cash flow per share5.25
Price/Cash flow per share35.31
Book value per share28.08
Tangible book value per share22.78
More ▼

Balance sheet in CNYView more

Meituan has a Debt to Total Capital ratio of 21.15%, a lower figure than the previous year's 26.95%.
Current ratio1.81
Quick ratio1.79
Total debt/total equity0.2681
Total debt/total capital0.2115
More ▼

Growth rates in CNY

SmartText is unavailable
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago
185.91
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.